MedTrace Logo

Network-Targeted Strategies for Efficient Community SARS-CoV-2 (COVID-19) Sampling

NCT04437706 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 602

Last updated 2024-06-06

No results posted yet for this study

Summary

The primary objective is to use "network targeted sampling design" to detect active and/or undiagnosed cases of COVID-19 in the community and determine the spread or distribution of 1) active infection, and 2) past exposure. The hypothesis is that there are many undiagnosed and/or asymptomatic people in the community who may be unknowingly spreading the virus or have been exposed and have antibodies. We propose to implement respondent-driven sampling (RDS) which leverages effort on the part of seed or index cases to recruit contacts for participation.

Conditions

Sponsors & Collaborators

Principal Investigators

  • Dana Pasquale, PhD · Duke University

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2020-12-11
Primary Completion
2022-07-25
Completion
2022-07-25

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04437706 on ClinicalTrials.gov